Table 3 Agreement between the laboratory-based WHO and Globorisk cardiovascular disease risk scores models according to the grouped risk.
Laboratory-based Globorisk risk category | Laboratory-based WHO risk category | Agreement (%) | Kappa* (SE**) | |||
|---|---|---|---|---|---|---|
Low | Moderate | High | Total | |||
All population | ||||||
Low | 5168 | 429 | 0 | 5597 | 91.4 | 0.75 (0.009) |
Moderate | 1 | 845 | 26 | 872 | ||
High | 0 | 126 | 201 | 327 | ||
Total | 5169 | 1400 | 227 | 6796 | ||
All males | ||||||
Low | 2316 | 214 | 0 | 2530 | 91.1 | 0.76(0.013) |
Moderate | 1 | 453 | 25 | 479 | ||
High | 0 | 40 | 109 | 149 | ||
Total | 2317 | 707 | 134 | 3158 | ||
All females | ||||||
Low | 2952 | 215 | 0 | 3067 | 94.4 | 0.74 (0.013) |
Moderate | 0 | 392 | 1 | 393 | ||
High | 0 | 86 | 92 | 178 | ||
Total | 2952 | 693 | 93 | 3638 | ||
